DaVita ROA 2010-2024 | DVA

Current and historical return on assets (ROA) values for DaVita (DVA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
DaVita ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-12-31 $0.94B $17.29B 5.41%
2024-09-30 $0.83B $17.50B 4.82%
2024-06-30 $0.86B $17.03B 5.04%
2024-03-31 $0.82B $17.43B 4.79%
2023-12-31 $0.69B $16.89B 4.11%
2023-09-30 $0.61B $16.93B 3.61%
2023-06-30 $0.47B $16.96B 2.77%
2023-03-31 $0.51B $16.73B 3.04%
2022-12-31 $0.56B $16.93B 3.29%
2022-09-30 $0.68B $16.96B 3.98%
2022-06-30 $0.83B $17.10B 4.84%
2022-03-31 $0.90B $17.09B 5.19%
2021-12-31 $0.98B $17.12B 5.57%
2021-09-30 $0.97B $17.63B 5.51%
2021-06-30 $0.86B $17.81B 4.97%
2021-03-31 $0.77B $17.65B 4.35%
2020-12-31 $0.78B $16.99B 4.37%
2020-09-30 $0.85B $17.05B 4.75%
2020-06-30 $0.83B $19.31B 4.63%
2020-03-31 $0.90B $17.60B 4.99%
2019-12-31 $0.81B $17.31B 4.20%
2019-09-30 $0.42B $17.45B 2.10%
2019-06-30 $0.14B $19.93B 0.67%
2019-03-31 $0.13B $22.61B 0.64%
2018-12-31 $0.16B $19.11B 0.83%
2018-09-30 $0.61B $19.36B 3.19%
2018-06-30 $0.54B $19.44B 2.80%
2018-03-31 $0.40B $18.94B 2.07%
2017-12-31 $0.66B $18.98B 3.46%
2017-09-30 $0.52B $19.01B 2.71%
2017-06-30 $1.30B $19.34B 6.83%
2017-03-31 $1.23B $19.39B 6.49%
2016-12-31 $0.88B $18.76B 4.70%
2016-09-30 $0.72B $18.93B 3.83%
2016-06-30 $0.36B $18.69B 1.93%
2016-03-31 $0.48B $18.51B 2.55%
2015-12-31 $0.27B $18.52B 1.44%
2015-09-30 $0.48B $18.90B 2.62%
2015-06-30 $0.45B $18.95B 2.47%
2015-03-31 $0.43B $18.37B 2.38%
2014-12-31 $0.72B $17.62B 4.07%
2014-09-30 $0.73B $18.10B 4.12%
2014-06-30 $0.68B $17.93B 3.93%
2014-03-31 $0.79B $17.40B 4.64%
2013-12-31 $0.63B $17.10B 3.79%
2013-09-30 $0.58B $16.83B 3.51%
2013-06-30 $0.59B $16.46B 3.92%
2013-03-31 $0.43B $16.41B 3.25%
2012-12-31 $0.54B $16.02B 4.74%
2012-09-30 $0.53B $10.82B 5.54%
2012-06-30 $0.52B $9.26B 5.75%
2012-03-31 $0.52B $9.16B 5.98%
2011-12-31 $0.48B $8.90B 5.60%
2011-09-30 $0.40B $8.71B 4.79%
2011-06-30 $0.38B $8.19B 4.75%
2011-03-31 $0.39B $8.32B 4.94%
2010-12-31 $0.41B $8.11B 5.22%
2010-09-30 $0.45B $7.63B 5.86%
2010-06-30 $0.44B $7.58B 5.77%
2010-03-31 $0.44B $7.69B 5.77%
2009-12-31 $0.42B $7.56B 5.68%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.238B $12.816B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.777B 18.97
Encompass Health (EHC) United States $10.200B 22.86
Chemed (CHE) United States $9.006B 28.86
Option Care Health (OPCH) United States $5.740B 27.52
Elanco Animal Health (ELAN) United States $5.213B 11.54
RadNet (RDNT) United States $3.681B 78.92
Amedisys (AMED) United States $3.039B 21.49
LifeStance Health (LFST) United States $2.561B 0.00
Addus HomeCare (ADUS) United States $1.797B 20.82
Astrana Health (ASTH) United States $1.554B 34.84
U.S Physical Therapy (USPH) United States $1.099B 28.05
Aveanna Healthcare Holdings (AVAH) United States $1.057B 0.00
Pennant (PNTG) United States $0.866B 34.93
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Bioqual (BIOQ) United States $0.051B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00